Sexually Transmitted Disease (STD) Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032 - PowerPoint PPT Presentation

About This Presentation

Sexually Transmitted Disease (STD) Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032


According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 20 March 2024
Slides: 14
Provided by: MarcelMikaelson


Transcript and Presenter's Notes

Title: Sexually Transmitted Disease (STD) Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

Global Sexually Transmitted Disease (STD)
Diagnostics Market Research and Forecast Report
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Sexually Transmitted Disease (STD)
    Diagnostics Market Global Industry Trends,
    Share, Size, Growth, Opportunity and Forecast
    2024-2032," the global sexually transmitted
    disease (STD) diagnostics market size reached US
    104.1 Billion in 2023.
  • Sexually transmitted disease (STD) diagnostics
    refers to scientific tools and techniques used to
    identify, detect, and confirm the presence of
    STDs in an individual. It includes polymerase
    chain reaction (PCR) tests, nucleic acid
    amplification tests (NAATs), enzyme-linked
    immunosorbent assays (ELISAs), point-of-care
    (PoC) devices, and self-testing kits. STD
    diagnostics utilize blood, urine, genital swab,
    and fluid samples to detect the presence of
    pathogens and markers related to STDs.
  • It is widely used to diagnose chlamydia,
    syphilis, gonorrhea, herpes, hepatitis B and C,
    human immunodeficiency virus (HIV), and human
    papillomavirus (HPV). STD diagnostics are highly
    efficient and accurate techniques that aid in the
    early detection of infections, enable timely
    intervention, prevent future complications, and
    increase patient outcomes.
  • Request for a PDF sample of this report

Report Description
  • Global Sexually Transmitted Disease (STD)
    Diagnostics Market Trends
  • The rising prevalence of STDs due to unprotected
    sexual intercourse and drug abuse is one of the
    key factors propelling the market growth. STD
    diagnostics are widely used to determine the
    severity of infections, prevent further
    transmission, and identify potential treatment
    options to improve patient outcomes. Furthermore,
    the growing awareness among the masses regarding
    early disease detection to avoid various future
    complications, such as cancer, congenital
    disabilities, and infertility, is acting as
    another growth-inducing factor. Additionally, the
    recent development of multiplex assays, which
    allows simultaneous detection of multiple STD
    pathogens in a single test, thus, reducing costs,
    saving time, and improving diagnostic accuracy,
    is positively influencing the market growth.
  • Besides this, the introduction of self-testing
    kits that allow individuals to conveniently test
    the presence of STDs in their homes without
    visiting healthcare facilities, which aids in
    improving accessibility, enhancing patient
    comfort, and maintaining privacy, is providing an
    impetus to the market growth. Apart from this,
    the implementation of supportive government
    policies to educate the masses about STDs,
    promote early detection, and provide access to
    high-quality treatment and testing facilities is
    contributing to the market growth. Other factors,
    including rising healthcare expenditure,
    increasing investment in the development of
    advanced diagnostic tools, and growing emphasis
    on sexual health among the masses, are
    anticipated to drive the market growth.
  • Looking forward, the market is expected to reach
    US 159.5 Billion by 2032, exhibiting a CAGR of
    4.71 during 2024-2032.
  • View Report TOC, Figures and Tables

Report Segmentation
  • Type Insights
  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Others
  • Device Type Insights
  • Laboratory Devices
  • Thermal Cycler PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Absorbance Microplate Reader Enzyme Linked
    Immunosorbent Assay (ELISA)

Report Segmentation
  • Others
  • Point of Care (PoC) Devices
  • Phone Chips (Microfluidics ICT)
  • Portable/Bench Top/Rapid Diagnostic Kits
  • End User Insights
  • Laboratory Testing
  • Point of Care (PoC) Testing
  • Regional Insights
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape with Key Players
  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Cepheid (Danaher Corporation)
  • F. Hoffmann-La Roche AG
  • Hologic Inc., Qiagen N.V.
  • Quidel Corporation
  • Siemens Healthineers AG (Siemens AG)

Key Questions Answered in the Report
Key Questions Answered in the Report
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Sexually Transmitted
    Disease (STD) Diagnostics Market    5.1  
     Market Overview    5.2    Market Performance 
      5.3    Impact of COVID-19  5.4    Market
  • 6     Market Breakup by Type    6.1    Chlamydia
    Testing        6.1.1 Market Trends        6.1.2
    Market Forecast    6.2    Syphilis Testing     
      6.2.1 Market Trends        6.2.2 Market
    Forecast    6.3    Gonorrhea Testing       
    6.3.1 Market Trends        6.3.2 Market

Table of Contents
  •     6.4    Herpes Simplex Virus Testing       
    6.4.1 Market Trends        6.4.2 Market
    Forecast    6.5    Human Papilloma Virus
    Testing        6.5.1 Market Trends        6.5.2
    Market Forecast    6.6    Human Immunodeficiency
    Virus Testing        6.6.1 Market Trends       
    6.6.2 Market Forecast    6.7    Chancroid
    Testing        6.7.1 Market Trends        6.7.2
    Market Forecast    6.8    Others        6.8.1
    Market Trends        6.8.2 Market Forecast7  
     Market Breakup by Device Type    7.1  
     Laboratory Devices        7.1.1 Market Trends 
          7.1.2 Key Segments 
    Thermal Cyclers - PCR  Lateral
    Flow Readers
  •   Flow Cytometers      Absorbance Microplate Reader - Enzyme
    Linked Immunosorbent Assay (ELISA)      Others        7.1.3 Market Forecast   
    7.2    Point of Care (PoC) Devices        7.2.1
    Market Trends
  • For more information, visit https//www.imarcgrou

  • 2023 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective

Contact Us
Visit us at
TELEPHONE 1-631-791-1145 E-MAIL
Write a Comment
User Comments (0)